ReleaseWire Connect

Fulcrum Therapeutics, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.

The Shareholders Foundation announced that a deadline is coming up on April 3, 2023 in the lawsuit filed for certain investors of Ryvyl Inc. (NASDAQ:RVYL).

An investor, who purchased NYSE:LUMN shares, filed a lawsuit against Lumen Technologies, Inc. over alleged violations of Federal Securities Laws.

An investigation was announced for investors of Veradigm Inc. (NASDAQ:MDRX) shares over potential securities laws violations by Veradigm Inc.

An investigation was announced over potential breaches of fiduciary duties by certain directors at Medical Properties Trust, Inc.

An investigation was announced for investors of Charles River Laboratories International, Inc. (NYSE:CRL) shares over potential securities laws violations by Charles River Laboratories International, Inc.

An investigation was announced for current long-term investors in shares of Olaplex Holdings, Inc. (NASDAQ:OLPX) concerning potential breaches of fiduciary duties by certain directors of Olaplex Holdings, Inc.

The Shareholders Foundation announced that a deadline is coming up on March 22, 2023 in the lawsuit filed for certain investors of Fate Therapeutics, Inc. (NASDAQ:FATE).

An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Design Therapeutics, Inc.

An investor, who purchased shares of Catalent, Inc. (NYSE:CTLT), filed a lawsuit over alleged violations of Federal Securities Laws by Catalent, Inc.